Uncategorised - European Medical Journal

Bariatric Surgery Alters Fibrinogen Profiles in MASLD

A recent study investigated how different naturally occurring fibrinogen variants relate to obesity, MASLD, and liver fibrosis severity.

ESMO Breast Cancer 2025: Taxane Chemotherapy Boosts Survival in Advanced Breast Cancer

A recent multi-centre study reveals taxane-based chemotherapy is linked to markedly better one-year survival in advanced triple-negative breast cancer with genomic instability, compared to platinum-based treatments.

Early Heart Risks After Stem Cell Transplant Revealed

A new study sheds light on the hidden cardiovascular risks lurking in the critical first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT).

CT Scan Radiation May Lead to Thousands of Future Cancers

A new study has projected that radiation exposure from computed tomography (CT) scans in the United States will result in approximately 103,000 future cancers.

Paediatric HIV Study Backs New Second-Line Antiretroviral Therapy

A new study provides strong evidence supporting the use of dolutegravir and TAF-emtricitabine for second-line antiretroviral therapy in children.

Can AI Predict Stroke Complications Before They Strike?

In a breakthrough meta-analysis designed for clinicians and healthcare professionals, machine learning tools have shown promising accuracy in predicting hemorrhagic transformation (HT) in patients with acute ischemic stroke (AIS).

Increasing UV Exposure and Rising Melanoma Risk in Canada

Young adults (18–29 years) had the highest UV exposure and sunburn rates, and were least likely to use protective clothing.

Combination Therapy Improves Outcomes in Prostate Cancer

he analysis also highlighted that treatment intensification with enzalutamide benefited patients regardless of baseline PSA.

Brensocatib Reduces Exacerbations in Patients with Bronchiectasis

A once-daily oral therapy targeting neutrophilic inflammation has shown promise in reducing exacerbations in patients with bronchiectasis.

ESMO Breast Cancer 2025: Gut Microbiome Linked to Breast Cancer Recurrence

New research presented at ESMO Breast 2025 reveals that certain gut bacteria and microbial functions are more common in breast cancer patients who later experience recurrence, highlighting the potential of the gut microbiome as a biomarker for relapse risk.